These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33323903)

  • 21. Subfoveal choroidal thickness changes after intravitreal ranibizumab injections in different patterns of diabetic macular edema using a deep learning-based auto-segmentation.
    Wang XN; Cai X; He S; Zhang X; Wu Q
    Int Ophthalmol; 2023 Dec; 43(12):4399-4407. PubMed ID: 33783677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
    Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM;
    Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
    Cicinelli MV; Cavalleri M; Querques L; Rabiolo A; Bandello F; Querques G
    Br J Ophthalmol; 2017 Dec; 101(12):1689-1693. PubMed ID: 28432109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
    Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
    Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.
    Mahapatra SK; Kumari S
    Indian J Ophthalmol; 2020 Mar; 68(3):490-493. PubMed ID: 32057010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema.
    Podkowinski D; Orlowski-Wimmer E; Zlabinger G; Pollreisz A; Mursch-Edlmayr AS; Mariacher S; Ring M; Bolz M
    Acta Ophthalmol; 2020 Jun; 98(4):e407-e415. PubMed ID: 31736269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Factors for Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant.
    Lee H; Kang KE; Chung H; Kim HC
    Korean J Ophthalmol; 2018 Apr; 32(2):116-125. PubMed ID: 29560616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema.
    Veritti D; Sarao V; Galiazzo F; Lanzetta P
    Ophthalmologica; 2017; 238(1-2):100-105. PubMed ID: 28558371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency.
    Adams OE; Schechet SA; Hariprasad SM
    Eur J Ophthalmol; 2021 Mar; 31(2):612-619. PubMed ID: 31964171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of anatomical biomarkers in subtypes of diabetic macular edema refractory to anti-vascular endothelial growth factor treated with dexamethasone implant.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Hernández-Bel L; Monferrer-Adsuara C; Mata-Moret L; Montero-Hernández J
    Eur J Ophthalmol; 2020 Jul; 30(4):764-769. PubMed ID: 30832509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study).
    Yoon YH; Boyer DS; Maturi RK; Bandello F; Belfort R; Augustin AJ; Li XY; Bai Z; Hashad Y;
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2639-2653. PubMed ID: 31654188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials.
    Danis RP; Sadda S; Li XY; Cui H; Hashad Y; Whitcup SM
    Br J Ophthalmol; 2016 Jun; 100(6):796-801. PubMed ID: 26581718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema.
    Kaldırım H; Savur F; Kırgız A; Atalay K
    Korean J Ophthalmol; 2020 Oct; 34(5):383-391. PubMed ID: 33099560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INVICTUS: Intravitreal anti-VEGF and dexamethasone implant comparison for the treatment of diabetic macular edema: A 12 months follow-up study.
    Comet A; Gascon P; Ramtohul P; Donnadieu B; Denis D; Matonti F
    Eur J Ophthalmol; 2021 Mar; 31(2):754-758. PubMed ID: 32507032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study.
    Fallico M; Avitabile T; Castellino N; Longo A; Russo A; Bonfiglio V; Parisi F; Furino C; Panozzo G; Scorcia V; Carnevali A; Bandello F; Parodi MB; Cennamo G; Cillino S; Vadalà M; Sunseri Trapani V; Cagini C; Fiore T; Lupidi M; Parravano M; Varano M; Giorno P; Boscia F; Giancipoli E; Eandi C; Le Mer Y; Reibaldi M
    Acta Ophthalmol; 2021 Feb; 99(1):e74-e80. PubMed ID: 32588978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
    Shah SU; Harless A; Bleau L; Maturi RK
    Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.